Research and Markets: Drug-Eluting Stents - Global Business Strategic Report - 2012-2017

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/q3v4bz/drugeluting) has announced the addition of the "Drug-Eluting Stents - Global Business Strategic Report" report to their offering.

“Drug-Eluting Stents - Global Business Strategic Report”

This report analyzes the worldwide markets for Drug-Eluting Stents in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of the World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.

The report profiles 39 companies including many key and niche players such as Abbott Vascular, Boston Scientific, Inc., Biosensors International Pte Ltd., Medtronic, Inc., and MIV Therapeutics Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary

1. MARKET OVERVIEW

2. COMPETITIVE LANDSCAPE

3. CORONARY STENTING - AN INSIGHT

4. COST AND PRICE ECONOMICS

5. RESEARCH AND DEVELOPMENT INITIATIVES - A HISTORIC PERSPECTIVE BUILDER

6. CLINICAL TRIALS UNDERTAKEN FROM 2002-2007

7. PRODUCT INNOVATIONS/INTRODUCTIONS

8. PRODUCT INNOVATIONS/INTRODUCTIONS - A HISTORIC PERSPECTIVE BUILDER

9. RECENT INDUSTRY ACTIVITY

10. INDUSTRY ACTIVITY - A HISTORIC PERSPECTIVE BUILDER

11. FOCUS ON SELECT GLOBAL PLAYERS

12. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. JAPAN

3. EUROPE

3a. FRANCE

3b. GERMANY

3c. ITALY

3d. THE UNITED KINGDOM

3e. SPAIN

3f. REST OF EUROPE

4. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 39 (including Divisions/Subsidiaries - 46)

Region/Country Players

• The United States 26
• Canada 3
• Japan 1
• Europe 11
• Germany 2
• The United Kingdom 3
• Italy 1
• Rest of Europe 5
• Asia-Pacific (Excluding Japan) 4
• Africa 1

For more information visit http://www.researchandmarkets.com/research/q3v4bz/drugeluting